Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Oligo (dT) 25 Beads: Protocols for High-Purity mRNA Isolatio

    2026-04-20

    Oligo (dT) 25 Beads: Technical Guidance for Eukaryotic mRNA Isolation

    What This Product Solves

    Efficient, high-purity mRNA isolation is foundational for transcriptomic research, especially when downstream assays such as first-strand cDNA synthesis, RT-PCR, or next-generation sequencing depend on intact and contaminant-free mRNA. Oligo (dT) 25 Beads address the need for a reliable, scalable method to purify polyadenylated mRNA from total RNA or directly from eukaryotic cells and tissues of animal or plant origin (source: product_spec). By leveraging the specific hybridization between surface-bound oligo (dT)25 sequences and the polyA tail of mRNA, these superparamagnetic beads streamline the transition from sample to analysis, reducing RNA loss and hands-on time compared to column-based or organic extraction methods. This product is not suitable for prokaryotic RNA or for isolating non-polyadenylated transcripts.

    For further background on how magnetic bead-based mRNA purification sets a reproducible standard for transcriptomics, see the internal article “Oligo (dT) 25 Beads: Transforming Magnetic Bead-Based mRNA Purification”. For advanced protocol troubleshooting and performance parameters, consult “Oligo (dT) 25 Beads: Magnetic Bead-Based mRNA Purification”.

    Protocol Parameters

    • Bead concentration | 10 mg/mL | All eukaryotic mRNA isolation workflows | Ensures sufficient binding capacity for typical RNA input amounts; supplied as a ready-to-use suspension | product_spec
    • Storage temperature | 4 °C | Routine laboratory storage | Maintains bead integrity and oligo (dT) functionality for 12–18 months; do not freeze to avoid aggregation or loss of magnetic properties | product_spec
    • Sample input | Total RNA or cell/tissue lysate (typical: up to several µg) | Direct mRNA capture from diverse eukaryotic sources | Supports both animal and plant tissue workflows, enabling direct mRNA purification without need for prior enrichment | workflow_recommendation
    • Elution volume | 10–50 µL (recommended) | Recovery of purified mRNA for downstream use | Minimizes dilution while maximizing mRNA yield for applications such as RT-PCR or cDNA synthesis | workflow_recommendation

    Workflow Setup and QC Checklist

    To implement Oligo (dT) 25 Beads for eukaryotic mRNA isolation, adhere to the following procedural and quality control points:

    1. Preparation: Gently resuspend the bead suspension by vortexing or pipetting before use. Avoid foaming.
    2. Sample Binding: Mix the beads with total RNA or lysate under recommended hybridization conditions (typically room temperature to 37 °C, in high-salt buffer to promote polyA-oligo(dT) binding). Incubation time varies with sample complexity; 10–30 minutes is standard (workflow_recommendation).
    3. Washing: Use the manufacturer’s wash buffer, or equivalent, to remove non-specifically bound material. Ensure complete removal of residual wash buffer before elution.
    4. Elution: Elute mRNA with nuclease-free water or low-salt buffer, pre-warmed if maximal yield is desired (typically 65 °C, 5–10 minutes; workflow_recommendation).
    5. QC: Assess mRNA integrity via microfluidics (e.g., Bioanalyzer) or agarose gel electrophoresis. Quantify yield by UV spectroscopy or fluorometric RNA assays.

    For storage, keep the unused bead suspension at 4 °C and avoid repeated freeze-thaw cycles (source: product_spec).

    Common Failure Modes and Fixes

    • Poor mRNA yield: Verify bead resuspension and bead-to-sample ratio. Insufficient mixing or incorrect buffer composition can reduce capture efficiency. Increase incubation time or check for excessive sample viscosity.
    • RNA degradation: Ensure all reagents and consumables are RNase-free. Work quickly, keep samples on ice when possible, and avoid prolonged room temperature steps.
    • Bead aggregation or loss of magnetic response: Do not freeze the beads. If aggregation occurs, gently pipette to disperse; persistent clumping may require discarding the affected aliquot (source: product_spec).
    • Low purity (rRNA or DNA contamination): Optimize wash steps and use recommended buffer stringency. Additional DNase treatment may be required prior to mRNA isolation for DNA-rich samples.

    Scope and Limitations

    Oligo (dT) 25 Beads are optimized for the isolation of polyA-tailed mRNA from eukaryotic sources (animal and plant). They are not suitable for prokaryotic RNA or for applications requiring the recovery of non-polyadenylated transcripts, such as ribosomal or certain non-coding RNAs. The binding capacity per mg of beads is determined by the manufacturer for standard RNA inputs; overloading can reduce both yield and purity. The beads are compatible with workflows for RT-PCR mRNA purification, first-strand cDNA synthesis primer function, and other molecular biology applications where intact, pure mRNA is essential. Strict adherence to recommended storage and handling is required to maintain performance (source: product_spec).

    Conclusion

    Oligo (dT) 25 Beads provide a robust, scalable solution for polyA tail mRNA capture in eukaryotic systems, supporting a wide array of downstream applications. By following established protocol parameters and quality assurance steps, researchers can achieve reproducible, high-purity mRNA isolation. For further reading on protocol optimization and method comparisons in magnetic bead-based mRNA purification, APExBIO’s internal resources offer additional guidance grounded in laboratory best practices.